CT - 医索

找到约 1704 条结果

Safety and efficacy of osimertinib plus consolidativestereotactic ablative radiation(SABR) inadvanced EGFR mutant non-small cell lungcancer(NSCLC)results from a multi-center Phase ltrial

医客学院 - 会议报告集

Outcomes with Perioperative Durvalumab in Patientswith Resectable NSCLc and Baseline N2 Lymph NodeInvolvement(N2 R-NSCLC)

医客学院 - 会议报告集

NRG-LU002Randomized Phase lllll Trial Of MaintenanceSystemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy For Limited Metastatic Non-Small Cell Lung Cancer

医客学院 - 会议报告集

Neoadjuvant nivolumab plus chemotherapy vschemotherapy in patients with resectable NSCLC4-year update from CheckMate 816

医客学院 - 会议报告集

Molecular residual disease analysis from the ADAURA trial of adjuvant osimertinib in patients with resected EGFR-mutated stage lB-lllA non-small cell lung cancer

医客学院 - 会议报告集

Milestones Early Detection to Nodal Status and Every thing in Between

医客学院 - 会议报告集

Managing Expectations WithAntibody-Drug Conjugates in Non-Small Cell Lung Cancer

医客学院 - 会议报告集

ICARUS-LUNG01 A phase 2 Study of Dato-DXd inpatients with previously treated advanced NSCLc, withsequential tissue biopsies and biomarkers analysis topredict treatment outcome

医客学院 - 会议报告集

Health-related quality of life (HRQoL) results for adjuvant alectinib vs chemotherapy in patients with resected ALK NSCLC data from ALINA

医客学院 - 会议报告集

Global Retrospective Study Comparing Consolidation ALK TKl to Durvalumab or Observation after Chemoradiation in Unresectable Locally Advanced ALK NSCLC

医客学院 - 会议报告集

今日实时热搜